Brexanolone by Sage Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval

Black Di­a­mond Ther­a­peu­tics is cut­ting an un­spec­i­fied num­ber of work­ers, in­clud­ing sev­er­al ex­ec­u­tives, and mak­ing changes to its pipeline in an ef­fort to ex­tend its

U.S. states and territories varied widely in their capacity to monitor people exposed to the H5N1 avian influenza virus, and in how they would recommend